Patents by Inventor Gunnar Jörg Floris Kaufmann

Gunnar Jörg Floris Kaufmann has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Intracellular delivery compounds
    Patent number: 10336829
    Abstract: Provided are compounds having the Formula I: pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and their use in the intracellular delivery of antibodies.
    Type: Grant
    Filed: October 20, 2016
    Date of Patent: July 2, 2019
    Assignee: Sorrento Therapeutics, Inc.
    Inventors: Yanwen Fu, Gunnar Jörg Floris Kaufmann, Heehyoung Lee, Ingale Sampat Lalaso
  • PROGRAMMABLE UNIVERSAL CELL RECEPTORS AND METHOD OF USING THE SAME
    Publication number: 20170112878
    Abstract: The present invention provides programmable universal cell receptors (PUCRs) comprising a catalytic antibody region, a transmembrane domain and a cytoplasmic domain. The PUCRs disclosed herein may be conjugated to a specificity agent in order to program the receptor for specificity to any molecule of interest. Also provided are nucleic acids encoding such PUCRs, and cells expressing the PUCRs. Such cells may be used in treating a variety of medical conditions and diseases including cancer and infectious diseases.
    Type: Application
    Filed: October 24, 2016
    Publication date: April 27, 2017
    Inventors: Gunnar Jörg Floris Kaufmann, Yanwen Fu, Yan-liang Zhang, James T. Patterson
  • INTRACELLULAR DELIVERY COMPOUNDS
    Publication number: 20170107289
    Abstract: Provided are compounds having the Formula I: pharmaceutically acceptable salts thereof, pharmaceutical compositions thereof, and their use in the intracellular delivery of antibodies.
    Type: Application
    Filed: October 20, 2016
    Publication date: April 20, 2017
    Inventors: Yanwen Fu, Gunnar Jörg Floris Kaufmann, Heehyoung Lee, Ingale Sampat Lalaso